Publication Date
1-17-2022
Keywords
breast cancer, survivorship, type 2 diabetes, health-related outcomes, electronic health records, health care resource utilization
Abstract
Purpose: Up to 74% of breast cancer survivors (BCS) have at least one preexisting comorbid condition, with diabetes (type 2) common. The purpose of this study was to examine differences in health-related outcomes (anemia, neutropenia, and infection) and utilization of health care resources (inpatient, outpatient, and emergency visits) in BCS with and without diabetes.
Methods: In this retrospective cohort study, data were leveraged from the electronic health records of a large health network linked to the Indiana State Cancer Registry. BCS diagnosed between January 2007 and December 2017 and who had received chemotherapy were included. Multivariable logistic regression and generalized linear models were used to determine differences in health outcomes and health care resources.
Results: The cohort included 6851 BCS, of whom 1121 (16%) had a diagnosis of diabetes. BCS were, on average, 55 (standard deviation: 11.88) years old, the majority self-reported race as White (90%), and 48.8% had stage II breast cancer. BCS with diabetes were significantly older (mean age of 60.6 [SD: 10.34] years) than those without diabetes and were often obese (66% had body mass index of ≥ 33). BCS with diabetes had higher odds of anemia (odds ratio: 1.43; 95% CI: 1.04, 1.96) and infection (odds ratio: 1.86; 95% CI: 1.35, 2.55) and utilized more outpatient resources (P < 0.0001).
Conclusions: Diabetes has a deleterious effect on health-related outcomes and health care resource utilization among BCS. These findings support the need for clinical practice guidelines to help clinicians manage diabetes among BCS throughout the cancer trajectory and for coordinated models of care to reduce high resource utilization.
Recommended Citation
Storey S, Zhang Z, Luo X, Metzger M, Jakka AR, Huang K, Von Ah D. Differences in health-related outcomes and health care resource utilization in breast cancer survivors with and without type 2 diabetes. J Patient Cent Res Rev. 2022;9:15-23. doi: 10.17294/2330-0698.1862
Included in
Endocrine System Diseases Commons, Endocrinology, Diabetes, and Metabolism Commons, Health Services Research Commons, Neoplasms Commons, Oncology Commons
Submitted
March 12th, 2021
Accepted
May 25th, 2021